Investing

Congress Ramps Up Investigations Of U.S. Venture Capital Firms Investing In Chinese Companies – Corporate and Company Law



To print this article, all you need is to be registered or login on Mondaq.com.

Last week, a select committee of the U.S. House of
Representatives sent letters to four venture capital (VC) firms
requesting detailed information about their investments in Chinese
companies developing technology involving artificial intelligence
(AI), semiconductors, and quantum computing. The letters are a
clear sign that Congress is ramping up its investigation of U.S.
investments in Chinese high-tech firms. U.S.-based VC firms that
regularly invest in Chinese companies should be aware that this is
a growing area of concern for Congress, review the information
requests carefully, and develop a plan for how to respond in the
event they are targeted next.

Background

The Biden administration and lawmakers are growing increasingly
concerned that U.S.-based VC firms are helping the Chinese
government develop emerging and critical technologies that could be
used to undermine U.S. national security by investing in Chinese
companies that work in high-tech areas, such as AI, semiconductors,
and quantum computing. Accordingly, the Biden administration is
reportedly drafting an executive order that would create an
outbound-investment screening regime. In addition, lawmakers have
drafted bills that would create a similar regime by statute, but
none of the bills have been passed into law.

In February 2023, Georgetown University’s Center for
Security and Emerging Technology (CSET) published a report analyzing outbound investments into
Chinese AI companies using investment data pulled from Crunchbase.
The report states that 167 U.S.-based investors participated in 401
investment transactions involving Chinese AI companies during the
time period from 2015 to 2021. According to the report, the top-10
U.S. investors in Chinese AI companies during this time period
were:
























U.S. Investor Number of transactions
in Chinese AI companies
Number of transactions
in all AI companies globally
Percentage of
investor’s total AI investment activity in China (by # of
transactions)
GGV Capital 43 112 38%
SOSV 38 284 13%
GSR Ventures 33 62 53%
BlueRun
Ventures
20 24 83%
DCM Ventures 16 35 46%
Qualcomm
Ventures
13 61 21%
Walden
International
12 31 39%
Intel Capital 11 144 8%
HAX 11 84 13%
GL Ventures 11 12 92%

Source: CSET.

The data shows only that a certain VC firm participated in a
particular funding round for a specific Chinese AI company, but the
data does not show how much money the VC firm invested as part of
the funding round. For example, although the report notes that GGV
Capital participated in 43 funding rounds for Chinese AI companies,
the report’s authors could not determine how much money GGV
Capital invested in each funding round.

Overall, the report noted that most investment in Chinese AI
companies comes from Chinese investors, and that Chinese AI
companies can also raise capital from other, non-U.S. sources.
Based on its findings, the report expressed doubt as to whether an
outbound-investment screening regime would have a “long-term
crippling effect” on China’s AI advancement. However, the
report noted that the existing U.S. outbound investment into China,
and the intangible benefits that flow from such investment, warrant
further investigation.

The Letters

Last week, on July 18, 2023, the Select Committee on the Chinese Communist Party
(China Select Committee or Committee) sent letters to four VC
firms—GGV Capital, GSR Ventures, Qualcomm Ventures, and
Walden International—requesting information relating to their
investments in Chinese AI and semiconductor companies, as well as
any investments they have made in China-based quantum-computing
firms. It appears from the letters that the Committee pulled the
names of these four VC firms directly from the CSET report
published earlier this year. It is not clear why the Committee sent
letters to only four of the VC firms included in CSET’s top-10
list, and not the other six.

In the letters, the Committee asserts that all investments made
in Chinese high-tech firms, particularly in the areas of AI,
semiconductors, and quantum computing, help the Chinese government
perpetrate human rights abuses and enhance China’s military
capabilities, regardless of whether the Chinese company that
receives the investment has ever worked with the Chinese government
or military. Because of China’s civil-military fusion policy,
the Committee takes the position that every Chinese company is the
de facto equivalent of a Chinese state-owned entity, and
that any dual-use technology developed by a Chinese company will
automatically be made available to the Chinese government who will
use the technology for nefarious purposes. As the Committee puts
it, “China’s policy of military-civil fusion . . . ensures
that no technology company in China is truly a private
company.”

The Committee concludes each letter by demanding that each VC
firm provide detailed information about its investments in China,
including:

  • a list of each Chinese AI, semiconductor, or quantum company in
    which it has made an investment;

  • the dollar amount of those investments;

  • all internal policies and procedures that relate to how the VC
    firm decides whether to invest in a company that is based in
    China;

  • the risk factors that the VC firm considers during the due
    diligence process when considering whether to invest in a company
    that is based in China;

  • the extent of Chinese state ownership in the VC firm’s
    investments;

  • whether the Chinese government or the Chinese Communist Party
    maintains a presence within the target company such as through a
    party committee; and

  • how the VC firm would respond if the U.S. government placed one
    of its Chinese portfolio companies on a trade restriction
    list.

Takeaways

  1. The China Select Committee is trying to fill in some of the
    gaps in the CSET report, including trying to determine how much
    U.S. capital is flowing into entities in China that are working on
    AI, semiconductors, and quantum computing. The requested
    information will likely be used to further refine plans for an
    outbound-investment screening mechanism for outbound investments in
    Chinese high-tech companies.

  2. US.-based VC firms that choose to continue investing in China
    should be aware that the U.S. Government is increasingly taking the
    view that all U.S. investments in Chinese high-tech
    companies—particularly companies working in the areas of AI,
    semiconductors, and quantum computing—undermine U.S. national
    security.

  3. U.S.-based VC firms are on notice that Congress is requesting
    detailed information about investments in Chinese AI,
    semiconductor, and quantum companies. VC firms should review the
    information requests carefully and develop a strategy for
    responding to similar requests if Congress targets their
    firms.

  4. VC firms should not discount the possibility that the China
    Select Committee will transfer information it receives to the
    Office of Foreign Assets Control, the Bureau of Industry and
    Security (BIS) End-User Review Committee, or other U.S. government
    bodies involved in imposing trade sanctions. If your VC firm was
    named in the February CSET report, consider updating the risk
    assessment of your relevant investments. Voluntary self-disclosure
    programs are available to divulge issues to regulatory agencies
    under friendlier and more forgiving settings. Congressional
    investigations have occasionally led to later regulatory
    enforcement, including the largest standalone administrative penalty in BIS
    history
    against Seagate Technology LLC and its Singaporean
    affiliate this year following a 2021 Senate committee report.

The content of this article is intended to provide a general
guide to the subject matter. Specialist advice should be sought
about your specific circumstances.

POPULAR ARTICLES ON: Corporate/Commercial Law from United States

There’s Still Time, But It’s Of The Essence

Caplin & Drysdale

Less than six months remain until the regulations implementing the beneficial ownership reporting requirements prescribed by the Corporate Transparency Act become effective on January 1, 2024.

A Lawyer Reads The New Yorker

Reed Smith

We’ve long been enamored with the idea that sources of insight reside all around us. Before we did drug and device law, we worked on consumer products liability cases that posed extraordinary…



Source link

Leave a Response